Test Price
2,800 AED✅ Home Collection Available
GLI3 Gene Greig Cephalopolysyndactyly Syndrome Genetic Test in UAE | 2800 AED | DNA Labs UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO certified cold‑chain processing and targeted NGS technology with Sanger validation.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Post‑test telephonic clinical guidance by DHA‑licensed Consultant Medical Genetics (Lina Osama Zaki Quteineh, DHA ID 9294403).
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This Next‑Generation Sequencing (NGS) test sequences the full coding regions of the GLI3 gene to detect pathogenic variants responsible for Greig cephalopolysyndactyly syndrome (GCPS). Conducted in our DHA‑licensed, ISO‑certified laboratory, it ensures 99.9% diagnostic sensitivity for accurate clinical decision‑making.
| Feature | Our GLI3 NGS Test | Whole Exome Sequencing (Alternative) |
|---|---|---|
| Precision | Full gene coverage, deep sequencing ≥100x | Broad but may miss deep intronic variants |
| Methodology | Targeted NGS, Sanger validation | Whole exome capture, bioinformatic filtering |
| Turnaround Time | 3–4 weeks | 6–8 weeks (complex analysis) |
| Price (AED) | 2,800 | 6,000+ |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA ID: 9294403) notes: “Facing a possible syndromic diagnosis can be daunting, but this test is a tool of empowerment. My team ensures that every result is contextualized with your child’s unique clinical picture, because genes tell only part of the story. We offer compassionate post‑test counselling to help you navigate the next steps confidently.”
Advisory Information
- This test requires informed consent and pre‑test genetic counselling (pedigree chart required) in accordance with Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- Do not discontinue any prescribed medication without prior physician approval.
- Variants of uncertain significance (VUS) may be reported; additional family studies may be recommended.
Exclusion Criteria
- Not suitable for emergency prenatal diagnosis; a dedicated genetic counsellor must be consulted beforehand.
- Red Flags: If you experience severe pain, bleeding, or signs of infection after sample collection, seek emergency care immediately.
- Mild hemolysis or lipemia does not affect DNA quality.
Patient FAQ & Clinical Guidance
1. What does the GLI3 genetic test diagnose?
This NGS test detects disease‑causing variants in the GLI3 gene responsible for Greig cephalopolysyndactyly syndrome, a rare autosomal dominant disorder.
2. Why is genetic counselling required before testing?
Pre‑test counselling ensures a thorough understanding of potential outcomes, inheritance patterns, and helps draw a detailed family pedigree essential for variant interpretation.
3. How soon will I receive my results?
Results are delivered within 3 to 4 weeks, accompanied by a telephonic post‑test guidance session to discuss findings and next clinical steps.
4. What sample types are accepted?
Blood (EDTA), extracted DNA, or one drop of blood on an FTA card. VIP Mobile Phlebotomy home collection is available daily from 8 AM to 11 PM.
UAE Regulatory & Data Privacy Adherence
This test fully complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data are processed exclusively within the UAE under strict confidentiality protocols. Our laboratory is DHA‑licensed (No. 1143) and ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139). Clinical safety and patient consent adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | GLI3 Gene Greig Cephalopolysyndactyly Syndrome Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Blood (EDTA), Extracted DNA, or FTA Card |
| Methodology Used | Next‑Generation Sequencing (NGS) with Sanger validation |
| ICD‑10‑CM Code | Q87.0 |
| LOINC Code | 95236-8 |
| DHA Facility License & Laboratory Address | License No. 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians